Not checkedNot checked for notices yet.
Effect of Enteral Propranolol in Acute Traumatic Brain Injury
Gad Sayd Gad, Ali R. Hamdan, Marwa Nasreldeen Elansary and 1 more
SVU - International Journal of Medical Sciences · 2023
doi:10.21608/svuijm.2022.152895.1355 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: Severe traumatic brain injury (TBI) is the predominant cause of death and disability following trauma. Several studies have observed improved survival in TBI patients exposed to β-blockers. Objectives: To evaluated effect of enteral propranolol on the outcomes of acute traumatic brain injury patients. Patients and methods: Forty patients with acute TBI were enrolled and divided into two group: group I (20 patients) were received 20 mg of oral Propranolol in 10cc water every 12 h for 10 days through nasogastric ryle, the group II (20 patients) were received 10cc water (placebo group). Results: Our results showed statistically significant (p-value < 0.001) increased percentage of neurological deficit in group II (20 patients, 100%) when compared with group I (0 patients, 0%), increased GCS after TTT in group I (12.3 ± 1.6) when compared with group II (7.85 ± 1.03). We also found statistically significant (p-value < 0.001) increased Karnofsky scale in group I (92 ± 6.2) when compared with group II (35.5 ± 5.1). Conclusion: Early enteral propranolol can be used for longer survival and more functional recovery in cases with isolated severe traumatic brain damage.
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.